CKD Clinical Trial - Integrated Palliative Care With Nephrology Care

Status Active, not recruiting

Clinical Trial Summary

This study is a pilot randomized controlled trial testing the effectiveness of integrated ambulatory supportive care visits with standard nephrology outpatient visits for six months in patients with advanced CKD. The study team hypothesizes that patients in the integrated care arm will trend towards improved symptom burden, improved quality of life scores and more engagement in advance care planning. Primary objectives: To test the impact of integrated ambulatory supportive care in nephrology care on symptom burden. Secondary: To test the impact of integrated ambulatory supportive care on quality of life and engagement in advance care planning and to demonstrate study feasibility.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04998110
Study type	Interventional
Source	NYU Langone Health
Contact
Status	Active, not recruiting
Phase	N/A
Start date	January 5, 2022
Completion date	October 15, 2024

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03277911` - Thyroid Dysfunction and Dyslipidemia in Patients With Chronic Kidney Diseases	N/A
Active, not recruiting	`NCT04008810` - Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease
Completed	`NCT05144971` - StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation
Active, not recruiting	`NCT05356325` - FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.
Not yet recruiting	`NCT04491669` - Screening of Gastrointestinal Tract Bleeding Causes Among Chronic Renal Failure Patients
Completed	`NCT04709120` - Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection
Terminated	`NCT03277183` - Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin	Phase 4
Enrolling by invitation	`NCT04491227` - Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection
Recruiting	`NCT06279429` - Sucrosomial Iron on Insomnia in Non-dialysis Chronic Kidney Disease Patients With Iron Deficiency Anemia	N/A
Recruiting	`NCT03501745` - Smart-CKD/BP Study	N/A
Recruiting	`NCT04708743` - The Tongue Features Associated With Chronic Kidney Disease
Recruiting	`NCT06416761` - Genetics in the Progression of Nephropathies
Completed	`NCT04119570` - CKD Report Card Pilot Trial	N/A
Completed	`NCT06374043` - Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.	Phase 4
Not yet recruiting	`NCT06094920` - Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial	Phase 4
Recruiting	`NCT04819217` - Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease	N/A
Completed	`NCT05970094` - Reduction of Metabolic Acidosis in Patients With Chronic Kidney Disease in Stage 4 and 5	N/A
Withdrawn	`NCT04782297` - Long Term Hemodialysis Catheters (LTHD) Post Market Clinical Follow up (PMCF)
Recruiting	`NCT05784389` - Reduction of Metabolic Acidosis in Patients With Chronic Kidney Disease in Stage 4 and 5	N/A
Recruiting	`NCT04630132` - Renal Ageing-sarcopenia Network